<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37395313</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-7560</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Diabetes/metabolism research and reviews</Title><ISOAbbreviation>Diabetes Metab Res Rev</ISOAbbreviation></Journal><ArticleTitle>Type 1 diabetes could begin with alterations in innate anti-viral immunity, which are already at this stage associated with HLA risk haplotypes.</ArticleTitle><Pagination><StartPage>e3678</StartPage><MedlinePgn>e3678</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/dmrr.3678</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To investigate if HLA risk haplotypes and HbA1c levels are associated with the expression levels of innate anti-viral immune pathway genes in type 1 diabetes.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We investigated RNA expression levels of innate anti-viral immune pathway genes in laser-dissected islets from two to five tissue sections per donor from the Diabetes Virus Detection study and the network of Pancreatic Organ Donors in relation to HLA risk haplotypes (non-predisposed and predisposed) and HbA1c levels (normal, elevated, and high).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The expression of innate anti-viral immune genes (TLR7, OAS1, OAS3 etc.) was significantly increased in individuals with predisposing vs non-predisposing HLA haplotypes. Also, the expression of several of the innate anti-viral immune genes from the HLA risk haplotype analysis was significantly increased in the group with high vs normal HbA1c. Furthermore, the gene expression of OAS2 was significantly increased in the group with high HbA1c vs elevated HbA1c.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Expression of innate anti-viral immune pathway genes was increased in individuals with predisposing HLA risk haplotypes and those with high HbA1c. This indicates that type 1 diabetes might well begin with alterations in innate anti-viral immunity, and already at this stage be associated with HLA risk haplotypes.</AbstractText><CopyrightInformation>© 2023 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buschard</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Mathias Høj</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0009-0005-2896-3751</Identifier><AffiliationInfo><Affiliation>Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krogvold</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerling</LastName><ForeName>Ivan C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Tennessee, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl-Jørgensen</LastName><ForeName>Knut</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haupt-Jorgensen</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4088-5862</Identifier><AffiliationInfo><Affiliation>Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diabetes Metab Res Rev</MedlineTA><NlmUniqueID>100883450</NlmUniqueID><ISSNLinking>1520-7552</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HLA distribution</Keyword><Keyword MajorTopicYN="N">HbA1c</Keyword><Keyword MajorTopicYN="N">TLR7</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">innate antiviral immunity</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37395313</ArticleId><ArticleId IdType="doi">10.1002/dmrr.3678</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Bruzzaniti S, Piemonte E, Lepore MT, Galgani M. Anti-viral innate immunity: is it where type 1 diabetes really begins? Diabetes Metab Res Rev. 2023:e3623. https://doi.org/10.1002/dmrr.3623</Citation></Reference><Reference><Citation>Pedersen K, Haupt-Jorgensen M, Krogvold L, et al. Genetic predisposition in the 2'-5'A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity. Diabetologia. 2021;64(8):1805-1815. https://doi.org/10.1007/s00125-021-05469-5</Citation></Reference><Reference><Citation>Lundberg M, Krogvold L, Kuric E, Dahl-Jørgensen K, Skog O. Expression of interferon-stimulated genes in insulitic pancreatic islets of patients recently diagnosed with type 1 diabetes. Diabetes. 2016;65(10):3104-3110. https://doi.org/10.2337/db16-0616</Citation></Reference><Reference><Citation>Krogvold L, Genoni A, Puggioni A, et al. Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study. Diabetologia. 2022;65(12):2108-2120. https://doi.org/10.1007/s00125-022-05779-2</Citation></Reference><Reference><Citation>Bonnevie-Nielsen V, Buschard K, Dyrberg T. Differential responsiveness to interferon-alpha in beta-cells and non-beta cells. Diabetes. 1996;45(6):818-821. https://doi.org/10.2337/diab.45.6.818</Citation></Reference><Reference><Citation>Mønsted MØ, Falck ND, Pedersen K, Buschard K, Holm LJ, Haupt-Jorgensen M. Intestinal permeability in type 1 diabetes: an updated comprehensive overview. J Autoimmun. 2021;122:102674. https://doi.org/10.1016/j.jaut.2021.102674</Citation></Reference><Reference><Citation>Estevez J, Martinez V. The local activation of toll-like receptor 7 (TLR7) modulates colonic epithelial barrier function in rats. Int J Mol Sci. 2023;24(2):1254. https://doi.org/10.3390/ijms24021254</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>